Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.
Intravenous gammaglobulin (IVGG) can improve the clinical course of several immune-mediated diseases. We report the first results of such treatment in eight patients with severe Guillain-Barré syndrome (GBS). We observed that IVGG was beneficial in at least some of the patients with severe GBS. These results should be confirmed in a randomized trial.
Kleyweg
R P
RP
Department of Neurology, University Hospital Dijkzigt, Rotterdam, The Netherlands.
van der Meché
F G
FG
Meulstee
J
J
D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011129:Polyradiculoneuropathy / Q000628:therapy*; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D005719:gamma-Globulins